Trial intelligence / Profile preview

Integrated malaria control with home-based management and seasonal malaria chemoprevention in Senegal

PACTR201305000551876Completed

Sponsor
Cheikh Anta Diop University
Start
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of amodiaquine, sulfadoxine + pyrimethamine and artemether + lumefantrine in malaria (2 arms), sponsored by Cheikh Anta Diop University. Primary endpoint: Incidence rate of malaria attacks. Started Sep 2010; status: completed.

02

Drugs

amodiaquinesulfadoxine + pyrimethamineartemether + lumefantrine
03

Conditions

malaria

Beyond the preview

Go deeper on PACTR201305000551876.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201305000551876.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call